Pathological lymphangiogenesis is modulated by galectin-8-dependent crosstalk between podoplanin and integrin-associated VEGFR-3

Nature Communications

Volumn 7, Issue , 2016, Pages

  Chen, Wei Sheng ^a,b   Cao, Zhiyi ^b   Sugaya, Satoshi ^b   Lopez, Maria J ^b   Sendra, Victor G ^b   Laver, Nora ^b   Leffler, Hakon ^c   Nilsson, Ulf J ^c   Fu, Jianxin ^d,e   Song, Jianhua ^d,e   Xia, Lijun ^d,e   Hamrah, Pedram ^b   Panjwani, Noorjahan ^a,b,f  

^a TUFTS UNIVERSITY   (United States)

^b NEW ENGLAND EYE CENTER   (United States)

^c LUND UNIVERSITY   (Sweden)

^d OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^e UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^f TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD45 ANTIGEN; GALECTIN 8; PODOPLANIN; RESIN; VASCULOTROPIN C; VASCULOTROPIN RECEPTOR 3; VERY LATE ACTIVATION ANTIGEN 1; VERY LATE ACTIVATION ANTIGEN 5; GALECTIN; GP38 PROTEIN, MOUSE; INTEGRIN; LGALS8 PROTEIN, HUMAN; MEMBRANE PROTEIN; PDPN PROTEIN, HUMAN;

BIOTECHNOLOGY; CARBOHYDRATE; CELLS AND CELL COMPONENTS; INHIBITOR; PATHOLOGY; PHYSIOLOGY; PROTEIN; RODENT; VIRUS;

ALLOTRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CORNEA TRANSPLANTATION; ENDOTHELIUM CELL; GRAFT REJECTION; GRAFT SURVIVAL; HERPES SIMPLEX KERATITIS; IMMUNOREACTIVITY; LYMPHANGIOGENESIS; MALE; MOLECULAR MECHANICS; MOUSE; NONHUMAN; UPREGULATION; ANIMAL; BIOLOGICAL MODEL; C57BL MOUSE; CELL MOTION; CORNEA; DRUG EFFECTS; EPITHELIUM CELL; HUMAN; INFLAMMATION; METABOLISM; PATHOLOGY;

MURINAE; MUS; SIMPLEXVIRUS;

ANIMALS; CELL MOVEMENT; CORNEA; EPITHELIAL CELLS; GALECTINS; HUMANS; INFLAMMATION; INTEGRINS; LYMPHANGIOGENESIS; MEMBRANE GLYCOPROTEINS; MICE, INBRED C57BL; MODELS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3;

EID: 84964319308     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms11302     Document Type: Article

References (70)

1. Kerjaschki, D. The lymphatic vasculature revisited. J. Clin. Invest. 124, 874-877 (2014)
2. Aspelund, A. et al. The Schlemms canal is a VEGF-C/VEGFR-3-responsive lymphatic-like vessel. J. Clin. Invest. 124, 3975-3986 (2014)
3. Dietrich, T. et al. Cutting edge: lymphatic vessels, not blood vessels, primarily mediate immune rejections after transplantation. J. Immunol. 184, 535-539 (2010)
4. Goyal, S., Chauhan, S. K. & Dana, R. Blockade of prolymphangiogenic vascular endothelial growth factor C in dry eye disease. Arch. Ophthalmol. 130, 84-89 (2012)
5. Lee, H. S. et al. Involvement of corneal lymphangiogenesis in a mouse model of allergic eye disease. Invest. Ophthalmol. Vis. Sci. 56, 3140-3148 (2015)
6. Thomson, B. R. et al. A lymphatic defect causes ocular hypertension and glaucoma in mice. J. Clin. Invest. 124, 4320-4324 (2014)
7. Wuest, T. R. & Carr, D. J. VEGF-A expression by HSV-1-infected cells drives corneal lymphangiogenesis. J. Exp. Med. 207, 101-115 (2010)
8. Witte, M. H. et al. Lymphangiogenesis and hemangiogenesis: potential targets for therapy. J. Surg. Oncol. 103, 489-500 (2011)
9. Markowska, A. I., Jefferies, K. C. & Panjwani, N. Galectin-3 protein modulates cell surface expression and activation of vascular endothelial growth factor receptor 2 in human endothelial cells. J. Biol. Chem. 286, 29913-29921 (2011)
10. Markowska, A. I., Liu, F. T. & Panjwani, N. Galectin-3 is an important mediator of VEGF- and bFGF-mediated angiogenic response. J. Exp. Med. 207 1981-1993(2010).
11. Ideo, H., Seko, A., Ishizuka, I. & Yamashita, K. The N-terminal carbohydrate recognition domain of galectin-8 recognizes specific glycosphingolipids with high affinity. Glycobiology 13, 713-723 (2003)
12. Ideo, H., Matsuzaka, T., Nonaka, T., Seko, A. & Yamashita, K. Galectin-8-Ndomain recognition mechanism for sialylated and sulfated glycans. J. Biol Chem. 286, 11346-11355 (2011)
13. Carlsson, S. et al. Affinity of galectin-8 and its carbohydrate recognition domains for ligands in solution and at the cell surface. Glycobiology 17 663-676 (2007)
14. Cueni, L. N. & Detmar, M. Galectin-8 interacts with podoplanin and modulates lymphatic endothelial cell functions. Exp. Cell Res. 315, 1715-1723 (2009)
15. Cueni, L. N. et al. Podoplanin-Fc reduces lymphatic vessel formation in vitro and in vivo and causes disseminated intravascular coagulation when transgenically expressed in the skin. Blood 116, 4376-4384 (2010)
16. Breiteneder-Geleff, S. et al. Podoplanin, novel 43-kd membrane protein of glomerular epithelial cells, is down-regulated in puromycin nephrosis. Am. J Pathol. 151, 1141-1152 (1997)
17. Schacht, V. et al. T1alpha/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema. EMBO J. 22, 3546-3556 (2003)
18. Fu, J. et al. Endothelial cell O-glycan deficiency causes blood/lymphatic misconnections and consequent fatty liver disease in mice. J. Clin. Invest. 118 3725-3737(2008).
19. Navarro, A., Perez, R. E., Rezaiekhaligh, M., Mabry, S. M. & Ekekezie, I. I T1alpha/podoplanin is essential for capillary morphogenesis in lymphatic endothelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 295, L543-L551 (2008)
20. Navarro, A., Perez, R. E., Rezaiekhaligh, M. H., Mabry, S. M. & Ekekezie, I. I. Polarized migration of lymphatic endothelial cells is critically dependent on podoplanin regulation of Cdc42. Am. J. Physiol. Lung Cell Mol. Physiol. 300 L32-L42(2011).
21. Maruyama, Y. et al. The effect of podoplanin inhibition on lymphangiogenesis under pathological conditions. Invest. Ophthalmol. Vis. Sci. 55, 4813-4822 (2014)
22. Kaneko, M. K. et al. Functional glycosylation of human podoplanin: glycan structure of platelet aggregation-inducing factor. FEBS Lett. 581, 331-336 (2007)
23. Pan, Y. et al. Podoplanin requires sialylated O-glycans for stable expression on lymphatic endothelial cells and for interaction with platelets. Blood 124 3656-3665(2014).
24. Chen, J., Alexander, J. S. & Orr, A. W. Integrins and their extracellular matrix ligands in lymphangiogenesis and lymph node metastasis. Int. J. Cell Biol. 2012 853703 (2012)
25. Wang, J. F., Zhang, X. F. & Groopman, J. E. Stimulation of beta 1 integrin induces tyrosine phosphorylation of vascular endothelial growth factor receptor-3 and modulates cell migration. J. Biol. Chem. 276, 41950-41957 (2001)
26. Zhang, X., Groopman, J. E. & Wang, J. F. Extracellular matrix regulates endothelial functions through interaction of VEGFR-3 and integrin alpha5beta1. J. Cell. Physiol. 202, 205-214 (2005)
27. Troncoso, M. F. et al. Galectin-8: a matricellular lectin with key roles in angiogenesis. Glycobiology 24, 907-914 (2014)
28. Kim, I. et al. Molecular cloning, expression, and characterization of angiopoietin-related protein. angiopoietin-related protein induces endothelial cell sprouting. J. Biol. Chem. 274, 26523-26528 (1999)
29. Abdel-Malak, N. A. et al. Angiopoietin-1 promotes endothelial cell proliferation and migration through AP-1-dependent autocrine production of interleukin-8 Blood 111, 4145-4154 (2008)
30. Yoon, C. M. et al. Sphingosine-1-phosphate promotes lymphangiogenesis by stimulating S1P1/Gi/PLC/Ca2 signaling pathways. Blood 112, 1129-1138 (2008)
31. Carlsson, S., Carlsson, M. C. & Leffler, H. Intracellular sorting of galectin-8 based on carbohydrate fine specificity. Glycobiology 17, 906-912 (2007)
32. Partridge, E. A. et al. Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis. Science 306, 120-124 (2004)
33. Yang, R. Y., Hill, P. N., Hsu, D. K. & Liu, F. T. Role of the carboxyl-terminal lectin domain in self-association of galectin-3. Biochemistry 37, 4086-4092 (1998)
34. Levy, Y. et al. It depends on the hinge: a structure-functional analysis of galectin-8, a tandem-repeat type lectin. Glycobiology 16, 463-476 (2006)
35. Deng, Y., Atri, D., Eichmann, A. & Simons, M. Endothelial ERK signaling controls lymphatic fate specification. J. Clin. Invest. 123, 1202-1215 (2013)
36. Zhou, F. et al. Akt/protein kinase B is required for lymphatic network formation, remodeling, and valve development. Am. J. Pathol. 177, 2124-2133 (2010)
37. Singh, N. et al. Soluble vascular endothelial growth factor receptor 3 is essential for corneal alymphaticity. Blood 121, 4242-4249 (2013)
38. Hajrasouliha, A. R. et al. Vascular endothelial growth factor-C promotes alloimmunity by amplifying antigen-presenting cell maturation and lymphangiogenesis. Invest. Ophthalmol. Vis. Sci. 53, 1244-1250 (2012)
39. Liesegang, T. J., Melton, 3rd L. J., Daly, P. J. & Ilstrup, D. M. Epidemiology of ocular herpes simplex. Incidence in Rochester, Minn, 1950 through 1982. Arch Ophthalmol. 107, 1155-1159 (1989)
40. Park, P. J. et al. Corneal lymphangiogenesis in herpetic stromal keratitis. Surv Ophthalmol. 60, 60-71 (2015)
41. Cursiefen, C. et al. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J. Clin. Invest. 113, 1040-1050 (2004)
42. Albuquerque, R. J. et al. Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth. Nat Med. 15, 1023-1030 (2009)
43. Garner, O. B. & Baum, L. G. Galectin-glycan lattices regulate cell-surface glycoprotein organization and signalling. Biochem. Soc. Trans. 36, 1472-1477 (2008)
44. Rabinovich, G. A., Toscano, M. A., Jackson, S. S. & Vasta, G. R. Functions of cell surface galectin-glycoprotein lattices. Curr. Opin. Struct. Biol. 17, 513-520 (2007)
45. Joukov, V. et al. Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J. 16, 3898-3911 (1997)
46. Wirzenius, M. et al. Distinct vascular endothelial growth factor signals for lymphatic vessel enlargement and sprouting. J. Exp. Med. 204, 1431-1440 (2007)
47. Vlahakis, N. E., Young, B. A., Atakilit, A. & Sheppard, D. The lymphangiogenic vascular endothelial growth factors VEGF-C and -D are ligands for the integrin alpha9beta1. J. Biol. Chem. 280, 4544-4552 (2005)
48. Karpanen, T. et al. Functional interaction of VEGF-C and VEGF-D with neuropilin receptors. FASEB J. 20, 1462-1472 (2006)
49. Herzog, B. H. et al. Podoplanin maintains high endothelial venule integrity by interacting with platelet CLEC-2. Nature 502, 105-109 (2013)
50. Reynolds, A. R. Potential relevance of bell-shaped and u-shaped dose-responses for the therapeutic targeting of angiogenesis in cancer. Dose Response 8 253-284 (2009)
51. Hirabayashi, J. et al. Oligosaccharide specificity of galectins: a search by frontal affinity chromatography. Biochim. Biophys. Acta 1572, 232-254 (2002)
52. Brewer, C. F., Miceli, M. C. & Baum, L. G. Clusters, bundles, arrays and lattices: novel mechanisms for lectin-saccharide-mediated cellular interactions. Curr Opin. Struct. Biol. 12, 616-623 (2002)
53. Yamagami, S. & Dana, M. R. The critical role of lymph nodes in corneal alloimmunization and graft rejection. Invest. Ophthalmol. Vis. Sci. 42 1293-1298(2001).
54. Yamagami, S., Dana, M. R. & Tsuru, T. Draining lymph nodes play an essential role in alloimmunity generated in response to high-risk corneal transplantation Cornea 21, 405-409 (2002)
55. Emami-Naeini, P. et al. Soluble vascular endothelial growth factor receptor-3 suppresses allosensitization and promotes corneal allograft survival. Graefes Arch. Clin. Exp. Ophthalmol. 252, 1755-1762 (2014)
56. Bryant-Hudson, K. M., Gurung, H. R., Zheng, M. & Carr, D. J. Tumor necrosis factor alpha and interleukin-6 facilitate corneal lymphangiogenesis in response to herpes simplex virus 1 infection. J. Virol. 88, 14451-14457 (2014)
57. Ling, S. et al. Development of new lymphatic vessels in alkali-burned corneas. Acta Ophthalmol. 87, 315-322 (2009)
58. Kerjaschki, D. et al. Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. J. Am. Soc Nephrol. 15, 603-612 (2004)
59. Kerjaschki, D. et al. Lymphatic endothelial progenitor cells contribute to de novo lymphangiogenesis in human renal transplants. Nat. Med. 12, 230-234 (2006)
60. Nykanen, A. I. et al. Targeting lymphatic vessel activation and CCL21 production by vascular endothelial growth factor receptor-3 inhibition has novel immunomodulatory and antiarteriosclerotic effects in cardiac allografts. Circulation 121, 1413-1422 (2010)
61. Choi, I. et al. Visualization of lymphatic vessels by Prox1-promoter directed GFP reporter in a bacterial artificial chromosome-based transgenic mouse Blood 117, 362-365 (2011)
62. Valenzuela, D. M. et al. High-throughput engineering of the mouse genome coupled with high-resolution expression analysis. Nat. Biotechnol. 21, 652-659 (2003)
63. Poland, P. A., Kinlough, C. L. & Hughey, R. P. Cloning, expression, and purification of galectins for in vitro studies. Methods Mol. Biol. 1207, 37-49 (2015)
64. Paranthan, R. R., Bargagna-Mohan, P., Lau, D. L. & Mohan, R. A robust model for simultaneously inducing corneal neovascularization and retinal gliosis in the mouse eye. Mol. Vis. 17, 1901-1908 (2011)
65. Panjwani, N., Moulton, P., Alroy, J. & Baum, J. Localization of lectin binding sites in human, cat, and rabbit corneas. Invest. Ophthalmol. Vis. Sci. 27 1280-1284 (1986).
66. Cao, R. et al. Mouse corneal lymphangiogenesis model. Nat. Protoc. 6, 817-826 (2011)
67. Rogers, M. S., Birsner, A. E. & DAmato, R. J. The mouse cornea micropocket angiogenesis assay. Nat. Protoc. 2, 2545-2550 (2007)
68. Sugaya, S. et al. Comparison of galectin expression signatures in rejected and accepted murine corneal allografts. Cornea 34, 675-681 (2015)
69. Sano, Y., Ksander, B. R. & Streilein, J. W. Minor H, rather than MHC. alloantigens offer the greater barrier to successful orthotopic corneal transplantation in mice. Transpl. Immunol. 4, 53-56 (1996)
70. Cursiefen, C. et al. Roles of thrombospondin-1 and -2 in regulating corneal and iris angiogenesis. Invest. Ophthalmol. Vis. Sci. 45, 1117-1124 (2004)